Treating PNH: Understanding Complement Inhibitors, Modes of Administration, and Coordinated Patient Care Needs : Episode 15
Opinion
Video
Ensuring PNH Treatment Access and Adherence to Therapies
Author(s):
Barriers to care and treatment adherence for patients diagnosed with PNH is discussed.
EP: 1.PNH Overview and Pathophysiology
EP: 2.Intravascular and Extravascular Hemolysis MoA in PNH
EP: 3.Utilizing Health Information Technology to Bridge Gaps in PNH Treatment Programming
EP: 4.Key Treatment Considerations for Patients Diagnosed With PNH
EP: 5.Complement System Role in PNH Treatment Approach
EP: 6.Eculizumab Impact on PNH Treatment Landscape and Unmet Needs in PNH Management
EP: 7.Efficacy End Points For PNH Treatment
EP: 8.Efficacy and Safety Trials Results of Complement Inhibitors
EP: 9.Treatment Adherence and Cost Considerations Surrounding Various Routes of PNH Treatment Administration
EP: 10.Investigational Therapies Paving New PNH Treatment Pathways
EP: 11.Key Financial Factors Associated With Typical PNH Treatment Journey
EP: 12.Navigating Transfusion Requirements in PNH Treatment
EP: 13.Considerations for Managing PNH Treatment Complications
EP: 14.Infection Risk Management Counseling For Patients Receiving Treatment for PNH
Now Viewing
EP: 15.Ensuring PNH Treatment Access and Adherence to Therapies
EP: 16.Financial Considerations Influencing Treatment Strategies in PNH Treatment Pathway
Video content above is prompted by the following questions:
- What strategies can effectively ensure seamless access to therapies (eg, partnering with specialized pharmacies for dispensing)?
- When considering treatment options, how do factors related to supporting and enhancing adherence influence your choice of therapy? Could you discuss the opportunities and approaches you leverage to promote optimal treatment adherence in this patient population?
Related Videos
Related Content
